PALI
Palisade Bio·NASDAQ
--
--(--)
--
--(--)
0.97 / 10
Underperform
Corporate fundamentals rate poor at 1.0/10. Beneficial factors: Current assets turnover ratio and Fixed assets turnover ratio, while concerns exist in Net profit / Total profit (%) and Gross profit margin (%). Resultant assessment: prudent.
Analysis Checks(3/5)
Inventory turnover ratio
Value23.20
Score2/3
Weight191.46%
1M Return-2.63%
Value23.20
Score2/3
Weight191.46%
1M Return-2.63%
Current assets turnover ratio
Value1.69
Score2/3
Weight-88.34%
1M Return1.15%
Value1.69
Score2/3
Weight-88.34%
1M Return1.15%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Gross profit margin (%)
Value25.80
Score1/3
Weight38.92%
1M Return-0.54%
Value25.80
Score1/3
Weight38.92%
1M Return-0.54%
Fixed assets turnover ratio
Value3889.55
Score3/3
Weight-64.36%
1M Return0.86%
Value3889.55
Score3/3
Weight-64.36%
1M Return0.86%
Inventory turnover ratio
Value23.20
Score2/3
Weight191.46%
1M Return-2.63%
Value23.20
Score2/3
Weight191.46%
1M Return-2.63%
Gross profit margin (%)
Value25.80
Score1/3
Weight38.92%
1M Return-0.54%
Value25.80
Score1/3
Weight38.92%
1M Return-0.54%
Current assets turnover ratio
Value1.69
Score2/3
Weight-88.34%
1M Return1.15%
Value1.69
Score2/3
Weight-88.34%
1M Return1.15%
Fixed assets turnover ratio
Value3889.55
Score3/3
Weight-64.36%
1M Return0.86%
Value3889.55
Score3/3
Weight-64.36%
1M Return0.86%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Is PALI undervalued or overvalued?
- PALI scores 0.97/10 on fundamentals and holds a Premium valuation at present. Backed by its -147.27% ROE, 0.00% net margin, -21.77 P/E ratio, 76.08 P/B ratio, and 84.40% earnings growth, these metrics solidify its Underperform investment rating.
